Patient Management

Rising Obesity and Diabetes Drive Global Surge in NAFLD, Highlighting Need for Better Treatments

As obesity and type 2 diabetes continue to rise globally, the prevalence of non-alcoholic fatty liver disease (NAFLD) is also increasing. Non-alcoholic steatohepatitis (NASH), a more severe form...

Corrie Berk,

DNP, MBA, APRN
Nurse Practitioner, Texas Liver Institute

Patient Management Guidelines

Guidance From Medscape

Expert opinions, case studies, quizzes, and more can be found at Medscape’s new portal for clinicians who treat metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis.

Managing Metabolic Dysfunction-associated Steatotic Liver and Metabolic Dysfunction-associated Steatohepatitis

The Journal of Hepatology provides detailed information for clinicians who treat patients who have been diagnosed with liver diseases formerly known as nonalcoholic steatohepatitis (NASH).

American Association for the Study of Liver Diseases (AASLD) Guidelines

AASLD offers guidelines that are current and revised regularly by a committee of experts in the field of hepatology.

Articles

NAFLD Affects 37% of US Adults, Driving New Care Pathway for Better Screening and Treatment

Nonalcoholic fatty liver disease (NAFLD) affects about 37% of adults in the United States and up to 70% of individuals...

CURATED BY:
Chantil D. Jeffreys,
FNP, DNP, JD

Alcohol and Metabolic Syndrome: A Synergistic Risk for Chronic Liver Disease

Alcohol use and metabolic syndrome (MetS) are both highly prevalent and often co-exist, contributing independently and synergistically to chronic liver...

CURATED BY:
Miu Lai (Milly) Ng,
FNP-BC, MPH (Harvard)

Meeting the Challenge of MASH

Worldwide, MASH is increasing, and this is a challenge for patients and clinicians. Addressing this challenge is the development of...

CURATED BY:
Miu Lai (Milly) Ng,
FNP-BC, MPH (Harvard)

Comorbidity: Health Benefits of Modest Weight Loss

Recent findings suggest that even small amounts of weight loss can lead to significant improvements in glycemic measures, triglycerides, blood...

CURATED BY:
Miu Lai (Milly) Ng,
FNP-BC, MPH (Harvard)

Global Obesity Crisis: Stigma and Inadequate Care Persist Despite Affecting 2 Billion Adults

The obesity crisis is a global health challenge, affecting over 2 billion adults and nearly tripling in prevalence over the...

CURATED BY:
Miu Lai (Milly) Ng,
FNP-BC, MPH (Harvard)

Nonalcoholic Fatty Liver Disease: A Growing Health Concern Linked to Type 2 Diabetes

Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver condition strongly linked to type 2 diabetes (T2D). In the...

CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Company
Contact

Partner with Us
Ambassador Program

Patient Management

Rising Obesity and Diabetes Drive Global Surge in NAFLD, Highlighting Need for Better Treatments

Corrie Berk,

Patient Management Guidelines

Guidance From Medscape

Managing Metabolic Dysfunction-associated Steatotic Liver and Metabolic Dysfunction-associated Steatohepatitis

American Association for the Study of Liver Diseases (AASLD) Guidelines

Articles

NAFLD Affects 37% of US Adults, Driving New Care Pathway for Better Screening and Treatment

Alcohol and Metabolic Syndrome: A Synergistic Risk for Chronic Liver Disease

Meeting the Challenge of MASH

Comorbidity: Health Benefits of Modest Weight Loss

Global Obesity Crisis: Stigma and Inadequate Care Persist Despite Affecting 2 Billion Adults

Nonalcoholic Fatty Liver Disease: A Growing Health Concern Linked to Type 2 Diabetes

© 2024 Point of Care Network, LLC. All Rights Reserved.

© 2024 Point of Care Network, LLC. All Rights Reserved.

Share